Skip to main content

Fusion Pharmaceuticals Short Interest Ratio and Short Volume

-0.24 (-2.85 %)
(As of 05/14/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume26,094 shs
Average Volume45,831 shs
Market Capitalization$347.09 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Fusion Pharmaceuticals (NASDAQ:FUSN) Short Interest Data

Current Short Volume208,300 shares
Previous Short Volume358,700 shares
Change Vs. Previous Month-41.93%
Dollar Volume Sold Short$1.91 million
Short Interest Ratio / Days to Cover4.7
Last Record DateApril, 15 2021
Outstanding Shares42,457,000 shares
Float Size24,170,000 shares
Short Percent of Float0.86%
Today's Trading Volume26,094 shares
Average Trading Volume45,831 shares
Today's Volume Vs. Average-43.06%

Short Interest Over Time

Fusion Pharmaceuticals (NASDAQ:FUSN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2021208,300 shares $1.91 million -41.9%0.9%4.7 $9.17
3/31/2021358,700 shares $3.56 million +7.2%1.7%7.4 $9.93
3/15/2021334,700 shares $3.89 million -2.0%1.6%5.7 $11.63
2/26/2021341,400 shares $4.10 million +1.3%1.6%5.8 $12.00
2/12/2021337,100 shares $3.96 million -0.3%1.6%5.5 $11.75
1/29/2021338,100 shares $3.83 million -7.3%1.5%5.8 $11.32
1/15/2021364,800 shares $4.45 million No Change1.6%6.6 $12.20

Fusion Pharmaceuticals (NASDAQ:FUSN) Short Interest FAQ

speech bubbles
speech bubbles

What is Fusion Pharmaceuticals' current short interest?

Short interest is the volume of Fusion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 208,300 shares of FUSN short. 0.86% of Fusion Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for Fusion Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Fusion Pharmaceuticals currently has a short interest ratio of 5.0.

What is a good short interest percentage for Fusion Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of Fusion Pharmaceuticals' floating shares are currently sold short.

Is Fusion Pharmaceuticals' short interest increasing or decreasing?

Fusion Pharmaceuticals saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 208,300 shares, a drop of 41.9% from the previous total of 358,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Fusion Pharmaceuticals' float size?

Fusion Pharmaceuticals currently has issued a total of 42,457,000 shares. Some of Fusion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fusion Pharmaceuticals currently has a public float of 24,170,000 shares.

How does Fusion Pharmaceuticals' short interest compare to its competitors?

0.86% of Fusion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fusion Pharmaceuticals: Alector, Inc. (10.91%), Translate Bio, Inc. (0.00%), Forma Therapeutics Holdings, Inc. (9.85%), Atara Biotherapeutics, Inc. (0.00%), Curis, Inc. (0.00%), Coherus BioSciences, Inc. (19.69%), Cortexyme, Inc. (26.33%), Black Diamond Therapeutics, Inc. (17.30%), Vaxcyte, Inc. (13.33%), and Scholar Rock Holding Co. (8.09%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Fusion Pharmaceuticals stock?

Short selling FUSN is an investing strategy that aims to generate trading profit from Fusion Pharmaceuticals as its price is falling. Fusion Pharmaceuticals' stock is trading down $0.24 today. To short Fusion Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Fusion Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fusion Pharmaceuticals?

A short squeeze for Fusion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FUSN, which in turn drives the price of the stock up even further.

How often is Fusion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FUSN, twice per month. The most recent reporting period available is April, 15 2021.

This page was last updated on 5/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.